Herantis Pharma Plc (HRTIS) - Financial Analysis Review Summary Herantis Pharma Plc (Herantis Pharma) is a specialty pharmaceutical company which develops novel pharmaceutical products for unmet clinical needs. The company concentrates on developing drugs for dry eye, Parkinson's disease, and secondary lymphedema. It offers pipeline products such as CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease, Cis-UCA emulsion cream for atopic dermatitis, Cis-UCA eye drops for dry ey...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.